PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,433,000 | -45.1% | 455,276 | -68.3% | 0.09% | -44.1% |
| Q1 2021 | $37,197,000 | +28.5% | 1,436,192 | 0.0% | 0.16% | +47.7% |
| Q4 2020 | $28,954,000 | -7.2% | 1,436,192 | -10.0% | 0.11% | -12.8% |
| Q3 2020 | $31,206,000 | -7.6% | 1,596,198 | -16.5% | 0.12% | -16.1% |
| Q2 2020 | $33,756,000 | +184.7% | 1,911,446 | +13.8% | 0.15% | +104.1% |
| Q1 2020 | $11,855,000 | +43.2% | 1,679,164 | +43.0% | 0.07% | +65.9% |
| Q4 2019 | $8,279,000 | -41.3% | 1,174,282 | 0.0% | 0.04% | -54.2% |
| Q3 2019 | $14,103,000 | +17.0% | 1,174,282 | +18.0% | 0.10% | +17.1% |
| Q2 2019 | $12,050,000 | +137.3% | 995,082 | +146.4% | 0.08% | +156.2% |
| Q1 2019 | $5,077,000 | – | 403,893 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $56,331,209 | 18.32% |
| Kynam Capital Management, LP | 1,375,000 | $31,625,000 | 4.08% |
| BVF INC/IL | 3,775,900 | $86,845,700 | 3.18% |
| Cormorant Asset Management, LP | 1,700,000 | $39,100 | 2.58% |
| RTW INVESTMENTS, LP | 4,600,799 | $105,818,377 | 2.20% |
| Ghost Tree Capital, LLC | 225,000 | $5,175,000 | 1.53% |
| 683 Capital Management, LLC | 791,000 | $18,193,000 | 1.36% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| Ikarian Capital, LLC | 211,400 | $4,862,200 | 1.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 105,486 | $2,426,178 | 1.00% |